- Roche to promote Digene's HPV test
- Cytyc withdraws acquisition of Digene
- Digene and Cytyc team up to offer HPV/Pap smear tests
- Cytyc, Digene co-promote each other's diagnostics in US
- Digene gets rights to Institut Pasteur patent
- Roche acquires HPV patents from Institut Pasteur
- Cytyc, Roche Diagnostics in co-promotion deal
- Abbott buys Vysis for $355mm
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.